标题
Protein Kinase CK1α Sustains B-Cell Receptor Signaling in Mantle Cell Lymphoma
作者
关键词
-
出版物
Frontiers in Oncology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-10-14
DOI
10.3389/fonc.2021.733848
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Targeting Protein Kinases in Blood Cancer: Focusing on CK1α and CK2
- (2021) Zaira Spinello et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Transcriptional programming drives Ibrutinib-resistance evolution in mantle cell lymphoma
- (2021) Xiaohong Zhao et al. Cell Reports
- Relapsed Mantle Cell Lymphoma: Current Management, Recent Progress, and Future Directions
- (2021) David A Bond et al. Journal of Clinical Medicine
- Emerging therapies in mantle cell lymphoma
- (2020) Walter Hanel et al. Journal of Hematology & Oncology
- Lights and Shade of Next-Generation Pi3k Inhibitors in Chronic Lymphocytic Leukemia
- (2020) Andrea Visentin et al. OncoTargets and Therapy
- Functions and regulation of the serine/threonine protein kinase CK1 family: moving beyond promiscuity
- (2020) Luke J. Fulcher et al. BIOCHEMICAL JOURNAL
- Phase 2 Study of the Safety and Efficacy of Umbralisib in Patients with CLL Who Are Intolerant to BTK or PI3Kδ Inhibitor Therapy
- (2020) Anthony R. Mato et al. BLOOD
- Activation of NF-κB in B cell receptor signaling through Bruton’s tyrosine kinase-dependent phosphorylation of IκB-α
- (2019) Marilena Pontoriero et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- FAM 83D directs protein kinase CK 1α to the mitotic spindle for proper spindle positioning
- (2019) Luke J Fulcher et al. EMBO REPORTS
- Ublituximab and Umbralisib in Relapsed/ Refractory B-cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
- (2019) Matthew Lunning et al. BLOOD
- Duvelisib for CLL/SLL and Follicular Non-Hodgkin Lymphoma
- (2019) Krish Patel et al. BLOOD
- MALT1 Phosphorylation Controls Activation of T Lymphocytes and Survival of ABC-DLBCL Tumor Cells
- (2019) Torben Gehring et al. Cell Reports
- Resistance to BTK inhibition by ibrutinib can be overcome by preventing FOXO3a nuclear export and PI3K/AKT activation in B-cell lymphoid malignancies
- (2019) Isha Kapoor et al. Cell Death & Disease
- BCR kinase inhibitors, idelalisib and ibrutinib, are active and effective in Richter syndrome
- (2018) Andrea Visentin et al. BRITISH JOURNAL OF HAEMATOLOGY
- Umbralisib, a novel PI3Kδ and casein kinase-1ε inhibitor, in relapsed or refractory chronic lymphocytic leukaemia and lymphoma: an open-label, phase 1, dose-escalation, first-in-human study
- (2018) Howard A Burris et al. LANCET ONCOLOGY
- Small Molecules Co-targeting CKIα and the Transcriptional Kinases CDK7/9 Control AML in Preclinical Models
- (2018) Waleed Minzel et al. CELL
- Umbralisib in combination with ibrutinib in patients with relapsed or refractory chronic lymphocytic leukaemia or mantle cell lymphoma: a multicentre phase 1–1b study
- (2018) Matthew S Davids et al. Lancet Haematology
- Role of protein kinases CK1α and CK2 in multiple myeloma: regulation of pivotal survival and stress-managing pathways
- (2017) Sabrina Manni et al. Journal of Hematology & Oncology
- Inactivation of CK1α in multiple myeloma empowers drug cytotoxicity by affecting AKT and β-catenin survival signaling pathways
- (2017) Sabrina Manni et al. Oncotarget
- Proteomic analysis of cell cycle progression in asynchronous cultures, including mitotic subphases, using PRIMMUS
- (2017) Tony Ly et al. eLife
- Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling
- (2016) June H. Myklebust et al. BLOOD
- Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents
- (2016) Arati A. Inamdar et al. Oncotarget
- Characterization of ibrutinib-sensitive and -resistant mantle lymphoma cells
- (2014) Jiao Ma et al. BRITISH JOURNAL OF HAEMATOLOGY
- CSNK1α1 mediates malignant plasma cell survival
- (2014) Y Hu et al. LEUKEMIA
- The CK1 Family: Contribution to Cellular Stress Response and Its Role in Carcinogenesis
- (2014) Uwe Knippschild et al. Frontiers in Oncology
- Class IA Phosphatidylinositol 3-Kinase Inhibition Inhibits Cell Growth and Proliferation in Mantle Cell Lymphoma
- (2013) Yoko Tabe et al. ACTA HAEMATOLOGICA
- Protein Kinase CK2 Inhibition Down Modulates the NF-κB and STAT3 Survival Pathways, Enhances the Cellular Proteotoxic Stress and Synergistically Boosts the Cytotoxic Effect of Bortezomib on Multiple Myeloma and Mantle Cell Lymphoma Cells
- (2013) Sabrina Manni et al. PLoS One
- Protein Kinase CK2 Protects Multiple Myeloma Cells from ER Stress-Induced Apoptosis and from the Cytotoxic Effect of HSP90 Inhibition through Regulation of the Unfolded Protein Response
- (2012) S. Manni et al. CLINICAL CANCER RESEARCH
- mTOR Generates an Auto-Amplification Loop by Triggering the βTrCP- and CK1α-Dependent Degradation of DEPTOR
- (2011) Shanshan Duan et al. MOLECULAR CELL
- Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era
- (2010) P. Perez-Galan et al. BLOOD
- Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death
- (2010) Francesco Piazza et al. BMC CANCER
- Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
- (2010) R. Eric Davis et al. NATURE
- Bruton’s tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domain
- (2009) Abdalla J. Mohamed et al. IMMUNOLOGICAL REVIEWS
- Casein kinase 1α governs antigen-receptor-induced NF-κB activation and human lymphoma cell survival
- (2009) Nicolas Bidère et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search